It's easy to think like this in hindsight given race have succeeded in getting rc220 to clinic. but the above q&a is in reference to that.
rc110 is viable without rc220 at a smaller scale, definitely not on the metrics of the triangle report.
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.040(3.38%) |
Mkt cap ! $198.9M | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.22 | $1.13 | $132.0K | 114.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2390 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 4805 | 1 |
View Market Depth
| Last trade - 15.57pm 04/07/2025 (20 minute delay) ? |
| RAC (ASX) Chart |